The Seed round was led by Maven Equity Finance to support team expansion and product development.
"We’re delighted to support GrandCare at this stage in the company’s development, with a real addressable market and innovative system we look forward to working with the business as it expands its customer reach and invests in product development. Stella and the team are highly experienced in the sector and dedicated to driving the business forward, with an increasing demand for the company’s technology solution, the business is set to experience rapid growth in the coming years."
The funding round was led by Longwall Venture Partners to support research and technology scaling.
"This investment gives us a platform to really accelerate in 2020 and scale-up the delivery of our game-changing technology to farmers across the country. We’re seeing rising demand from around the world for new technologies to help farmers grow crops in ways that mitigate against the effects of climate change and ever-increasing extreme weather events."
The seed round was backed by Amadeus Capital Partners, Delin Ventures and Kindred Capital to fund the commercial launch of its manufacturing technology.
"Hundreds of clinical trials and a few recently marketed products have shown the revolutionary potential of CGTs. But this potential will never be realised unless we can remove the current bottleneck around scalable manufacturing. Ori Biotech has developed an innovative platform technology to facilitate scalable manufacturing that could eventually enable millions of patients to get access to the next generation of personalised medicines,"
The financing round was supported by Equity Gap, Scottish Investment Bank, Old College Capital and Hillhouse Group.
"MiAlgae has essentially taken a by-product from one industry and turned it into a solution for another industry. Through the application of biotechnology, MiAlgae is finding solutions to feed the world’s population, and with the global aquaculture industry set to double in size in the next ten years, this is a very promising business indeed."
The London-based esports betting platform raised the funds to support its platform development and growing user waitlist.
"We have been in an Alpha for half a year now and are already seeing significant turnover. We are building everything in-house and are keen to offer the best experience for esports fans in the market. Customers have been loving the platform and we in turn are fine-tuning the product specifically for them. Every day, our waitlist for access keeps growing and we are extremely pleased with the way the product been received so far."
